Literature DB >> 10397607

Enzymatic degradation of epichlorohydrin crosslinked starch microspheres by alpha-amylase.

G Hamdi1, G Ponchel.   

Abstract

PURPOSE: The influence of chemical parameters on the sensitivity to enzymatic degradation by alpha-amylase of starch microspheres cross-linked by epichlorohydrin was studied.
METHODS: Starch microspheres were prepared using epichlorohydrin as a crosslinking agent. Their swelling degree, reflecting the number of glycerol diether bridges in the polymeric network, and the number of non-crosslinking monoglycerol ether groups corresponding to a side-reaction of epichlorohydrin with starch were determined. Degradation rates of the microspheres in presence of porcine alpha-amylase were determined by a microvolumetric method.
RESULTS: Degradation by alpha-amylase was surface-controlled and could be modulated by the introduction in the polymeric network of: (i) non-hydrolysable alpha-1,6 bonds related to the presence of amylopectin in the raw starch, (ii) glycerol diether and, (iii) monoether groups, all of these being likely to block the activity of alpha-amylase. In the case of highly cross-linked microspheres, the number of glycerol monoether pendent chains had a predominant effect on the degradation rate which ranged between 10(-2) and 10(-5) min(-1).
CONCLUSIONS: It was possible to modulate simultaneously the swelling degree and the enzymatic degradability of starch microspheres by adjusting the chemical parameters during the crosslinking reaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397607     DOI: 10.1023/a:1018878120100

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  An original method for studying in vitro the enzymatic degradation of cross-linked starch microspheres.

Authors:  G Hamdi; G Ponchel; D Duchêne
Journal:  J Control Release       Date:  1998-11-13       Impact factor: 9.776

2.  Alpha-amylase structure and activity.

Authors:  E A MacGregor
Journal:  J Protein Chem       Date:  1988-08

3.  Preparation of ethylcellulose microcapsules containing theophylline by using emulsion non-solvent addition method.

Authors:  H Chen; J C Wu; H Y Chen
Journal:  J Microencapsul       Date:  1995 Mar-Apr       Impact factor: 3.142

4.  Three approaches to the analysis of trace formaldehyde in bulk and dosage from pharmaceuticals.

Authors:  G J Manius; L F Wen; D Palling
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

5.  Multiple attack mechanism in the porcine pancreatic alpha-amylase hydrolysis of amylose and amylopectin.

Authors:  A K Mazur; H Nakatani
Journal:  Arch Biochem Biophys       Date:  1993-10       Impact factor: 4.013

6.  Preparation of egg albumin microcapsules and microspheres.

Authors:  T Ishizaka; K Endo; M Koishi
Journal:  J Pharm Sci       Date:  1981-04       Impact factor: 3.534

7.  Microencapsulation III: Preparation of invertase microcapsules.

Authors:  P Rambourg; J Lévy; M C Lévy
Journal:  J Pharm Sci       Date:  1982-07       Impact factor: 3.534

8.  The effect of different dosages of degradable starch microspheres (Spherex) on the distribution of doxorubicin regionally administered to the rat.

Authors:  H Teder; C J Johansson
Journal:  Anticancer Res       Date:  1993 Nov-Dec       Impact factor: 2.480

Review 9.  Limiting factors of starch hydrolysis.

Authors:  P Colonna; V Leloup; A Buléon
Journal:  Eur J Clin Nutr       Date:  1992-10       Impact factor: 4.016

10.  Characterization of polyacryl starch microparticles as carriers for proteins and drugs.

Authors:  P Artursson; P Edman; T Laakso; I Sjöholm
Journal:  J Pharm Sci       Date:  1984-11       Impact factor: 3.534

  10 in total
  7 in total

1.  Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.

Authors:  Adam J Cole; Allan E David; Jianxin Wang; Craig J Galbán; Hannah L Hill; Victor C Yang
Journal:  Biomaterials       Date:  2010-12-21       Impact factor: 12.479

2.  Dynamics of controlled release of heparin from swellable crosslinked starch microspheres.

Authors:  A K Bajpai; Smitha Bhanu
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 3.896

3.  Athermal nerve sparing robot-assisted radical prostatectomy: initial experience with microporous polysaccharide hemospheres as a topical hemostatic agent.

Authors:  Rafael Nunez-Nateras; Kimberly J Hurd; Erin N Ferrigni; Erik P Castle; Paul E Andrews; Mitchell R Humphreys
Journal:  World J Urol       Date:  2011-12-25       Impact factor: 4.226

4.  Preparation of Slowly Digested Corn Starch Using Branching Enzyme and Immobilized α-Amylase.

Authors:  Ruomin Li; Huanxin Zhang; Saikun Pan; Mengwei Zhu; Yi Zheng
Journal:  ACS Omega       Date:  2022-05-19

5.  Renal injury and the application of polysaccharide hemospheres: a laparoscopic experimental model.

Authors:  Mitchell R Humphreys; James E Lingeman; Colin Terry; Erik P Castle; Paul E Andrews; Matthew T Gettman; Mark H Ereth
Journal:  J Endourol       Date:  2008-06       Impact factor: 2.942

6.  Development of biodegradable starch microspheres for intranasal delivery.

Authors:  A V Yadav; H H Mote
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

7.  Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures.

Authors:  Brian A Bruckner; Lance N Blau; Limael Rodriguez; Erik E Suarez; Uy Q Ngo; Michael J Reardon; Matthias Loebe
Journal:  J Cardiothorac Surg       Date:  2014-08-02       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.